Growth factors: possible roles for clinical management of the short bowel syndrome.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Seminars in Pediatric Surgery

• Publication date

  2010-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.sempedsurg.2009.11.010PMID 20123272PMCID PMC2891767
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Short Bowel Patients Treated for Two Years with Glucagon-Like Peptide 2 (GLP-2): Compliance, Safety, and Effects on Quality of Life

  2009cited by this paper
• Early but not late administration of glucagon-like peptide-2 following ileo-cecal resection augments putative intestinal stem cell expansion.

  2009cited by this paper
• Glucagon-like peptide-2 increases mesenteric blood flow in humans

  2009cited by this paper
• Effects of thyroid hormone on the adaptation in short bowel syndrome.

  2009cited by this paper
• Intestinal hormones and growth factors: effects on the small intestine.

  2009cited by this paper
• The Growth Hormone Cascade and Its Role in Mammalian Growth

  2009cited by this paper
• Protective effects of glucagon‐like peptide 2 on intestinal ischemia‐reperfusion rats

  2008cited by this paper
• Pharmacokinetics, Safety, and Tolerability of Teduglutide, a Glucagon‐Like Peptide‐2 (GLP‐2) Analog, Following Multiple Ascending Subcutaneous Administrations in Healthy Subjects

  2008cited by this paper
• GLP-2 Administration Results in Increased Proliferation but Paradoxically an Adverse Outcome in a Juvenile Piglet Model of Short Bowel Syndrome

  2008cited by this paper
• How growth hormone controls growth, obesity and sexual dimorphism.

  2008cited by this paper
• P093 TWO DOSE-EQUIVALENT, 21-DAYS, SUBCUTANEOUS (S.C.), GLUCAGON-LIKE PEPTIDE 2 (GLP-2) DOSING REGIMENS, 1.0 MG CONTINUOUSLY VERSUS 0.33 MG THREE TIME DAILY (TID), IN THE TREATMENT OF SHORT BOWEL SYNDROME (SBS) PATIENTS

  2008cited by this paper
• 212 Teduglutide, a Novel GLP-2 Analog, in the Management of Short Bowel Syndrome (SBS) Patients Dependent On Parenteral Nutrition: A Multicenter, Multinational Placebo-Controlled Clinical Trial

  2008cited by this paper
• Pediatric short-bowel syndrome: the cost of comprehensive care.

  2008cited by this paper
• Epidermal growth factor receptor signaling modulates apoptosis via p38alpha MAPK-dependent activation of Bax in intestinal epithelial cells.

  2007cited by this paper
• Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2.

  2007cited by this paper
• Combined pharmacotherapy that increases proliferation and decreases apoptosis optimally enhances intestinal adaptation.

  2006cited by this paper
• Teduglutide for the Treatment of Short Bowel Syndrome

  2006cited by this paper
• Glucagon-like Peptide-2 Induces a Specific Pattern of Adaptation in Remnant Jejunum

  2006cited by this paper
• The epidermal growth factor receptors and their family of ligands: their putative role in atherogenesis.

  2006cited by this paper
• Robbins and Cotran Pathologic Basis of Disease: 7th Edition

  2005cited by this paper
• The effect of growth hormone supplementation on late nutritional independence in pediatric patients with short bowel syndrome.

  2005cited by this paper
• Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients

  2005cited by this paper
• GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors.

  2005cited by this paper
• Effect of leptin on intestinal re-growth following massive small bowel resection in rat

  2005cited by this paper
• Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome.

  2005cited by this paper
• Effect of sex and sex hormones on structural intestinal adaptation after massive small bowel resection in rats.

  2005cited by this paper
• Impaired intestinal cell proliferation and cell death in leptin-deficient obese mice.

  2005cited by this paper
• Epidermal growth factor and bombesin act synergistically to support intestinal adaptation in rats with massive small bowel resection

  2005cited by this paper
• Teduglutide ([Gly2]GLP‐2) protects small intestinal stem cells from radiation damage

  2004cited by this paper
• Smooth muscle overexpression of IGF-I induces a novel adaptive response to small bowel resection.

  2004cited by this paper
• Effect of recombinant human growth hormone and enteral nutrition on short bowel syndrome.

  2004cited by this paper
• Results of growth trophic therapy in children with short bowel syndrome.

  2004cited by this paper
• Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats.

  2004cited by this paper
• Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome.

  2004cited by this paper
• Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: who will have the last word?

  2004cited by this paper
• IGF-I treatment facilitates transition from parenteral to enteral nutrition in rats with short bowel syndrome.

  2003influential reference
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• IGF-I augments resection-induced mucosal hyperplasia by altering enterocyte kinetics.

  2003cited by this paper
• Effects of bowel rehabilitation and combined trophic therapy on intestinal adaptation in short bowel patients.

  2003cited by this paper
• Mortality and economics in short bowel syndrome.

  2003cited by this paper
• Localization of postresection EGF receptor expression using laser capture microdissection.

  2003cited by this paper
• International Union of Pharmacology. XXXV. The Glucagon Receptor Family

  2003cited by this paper
• Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study.

  2003cited by this paper
• Short-term Administration of Glucagon-like Peptide-2. Effects on Bone Mineral Density and Markers of Bone Turnover in Short-Bowel Patients with No Colon

  2002cited by this paper
• Biological actions and therapeutic potential of the glucagon-like peptides.

  2002cited by this paper
• Effects of growth hormone (rhGH) and glutamine supplemented parenteral nutrition on intestinal adaptation in short bowel rats.

  2001cited by this paper
• Systemic GLP-2 levels do not limit adaptation after distal intestinal resection.

  2001cited by this paper
• Modulation of specific intestinal epithelial progenitors by enteric neurons

  2001cited by this paper
• Proglucagon-derived peptides in intestinal epithelial proliferation: glucagon-like peptide-2 is a major mediator of intestinal epithelial proliferation in rats.

  2001cited by this paper
• Growth hormone plus high protein diet promotes adaptation after massive bowel resection in aged rats.

  2001cited by this paper
• Intestinal Growth Adaptation and Glucagon-like Peptide 2 in Rats with Ileal–Jejunal Transposition or Small Bowel Resection

  2001cited by this paper
• Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon.

  2001cited by this paper
• Glutamine enhances the gut-trophic effect of growth hormone in rat after massive small bowel resection.

  2001cited by this paper
• The Glucagon Receptor Family

  2000cited by this paper
• Enzymatic- and renal-dependent catabolism of the intestinotropic hormone glucagon-like peptide-2 in rats.

  2000cited by this paper
• Epidermal Growth Factor Receptor Is Increased in Rabbit Intestinal Brush Border Membrane After Small Bowel Resection

  2000cited by this paper
• Enteroendocrine localization of GLP-2 receptor expression in humans and rodents.

  2000cited by this paper
• Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon

  2000cited by this paper
• Epidermal growth factor is critical for intestinal adaptation following small bowel resection

  2000cited by this paper
• Epidermal growth factor alters the bax:bcl-w ratio following massive small bowel resection.

  2000cited by this paper
• In vivo and in vitro degradation of glucagon-like peptide-2 in humans.

  2000cited by this paper
• Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study

  2000cited by this paper
• What's new in the management of short gut syndrome in children.

  2000cited by this paper
• An evaluation of single dose administration of ALX-0600, a GLP-2 analog, in healthy male subjects

  2000cited by this paper
• Severe short-bowel syndrome in children: Clinical experience

  2000cited by this paper
• Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2.

  1999cited by this paper
• Intestinal overexpression of EGF in transgenic mice enhances adaptation after small bowel resection.

  1999cited by this paper
• Effect of growth hormone, glutamine, and diet on body composition in short bowel syndrome: a randomized, controlled study.

  1999cited by this paper
• Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans.

  1999cited by this paper
• Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2.

  1999cited by this paper
• Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure

  1999cited by this paper
• Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome.

  1999influential reference
• Small bowel adaptation with growth hormone and glutamine after massive resection of rat's small bowel.

  1999cited by this paper
• Intestinal lengthening and growth hormone in extreme short bowel syndrome: a case report.

  1999cited by this paper
• Severe short-bowel syndrome in children. Clinical experience.

  1999cited by this paper
• The distribution of endogenous epidermal growth factor after small bowel resection suggests increased intestinal utilization during adaptation.

  1999cited by this paper
• Molecular Basis of Intestinal Adaptation: The Role of the Insulin‐like Growth Factor System

  1998influential reference
• Adaptation after small bowel resection is attenuated by sialoadenectomy: the role for endogenous epidermal growth factor.

  1998cited by this paper
• Epidermal growth factor augments adaptation following small bowel resection: optimal dosage, route, and timing of administration.

  1998cited by this paper
• GLP-2 augments the adaptive response to massive intestinal resection in rat.

  1998cited by this paper
• Comparison of interleukin-11 and epidermal growth factor on residual small intestine after massive small bowel resection.

  1998cited by this paper
• Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs.

  1998cited by this paper
• Role of the 6‐20 disulfide bridge in the structure and activity of epidermal growth factor

  1998cited by this paper
• Epidermal growth factor and neurotensin induce microvillus hypertrophy following massive enterectomy

  1997cited by this paper
• Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I.

  1997cited by this paper
• A defective EGF-receptor in waved-2 mice attenuates intestinal adaptation.

  1997cited by this paper
• A comparison of the effect of growth factors on intestinal function and structure in short bowel syndrome.

  1997cited by this paper
• Intestinal growth-promoting properties of glucagon-like peptide-2 in mice.

  1997cited by this paper
• Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study.

  1997cited by this paper
• Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome.

  1997cited by this paper
• Epidermal Growth Factor Improves Intestinal Adaptation during Somatostatin Administrationin Vivo

  1996cited by this paper
• Epidermal growth factor improves intestinal adaptation during somatostatin administration in vivo.

  1996cited by this paper
• The effect of GIP and glucagon-like peptides on intestinal basolateral membrane hexose transport.

  1996cited by this paper
• Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

  1996cited by this paper
• Current use and clinical outcome of home parenteral and enteral nutrition therapies in the United States.

  1995cited by this paper
• Regulation and localization of the insulin-like growth factor system in small bowel during altered nutrient status.

  1995cited by this paper
• A New Treatment for Patients with Short‐Bowel Syndrome Growth Hormone, Glutamine, and a Modified Diet

  1995cited by this paper
• Short bowel syndrome.

  1995cited by this paper
• Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome.

  1995cited by this paper
• Glucocorticoid regulation of rat whey acidic protein gene expression involves hormone-induced alterations of chromatin structure in the distal promoter region.

  1994cited by this paper

• An exploratory in vitro co-culture of enteric neurons and smooth muscle cells demonstrates neuronal contribution to muscle layer formation

  2026cites this paper
• Fabrication and in vivo characterization of FRESH-based 3D printed chitosan construct for small intestine regeneration

  2025cites this paper
• The Gut’s Secret Code: Bowel Microbiota as a Biomarker for Adaptation

  2025influential citation
• CRISPR-edited, cell-based future-proof meat and seafood to enhance global food security and nutrition

  2024cites this paper
• Xenotransplanted human organoids identify transepithelial zinc transport as a key mediator of intestinal adaptation

  2024cites this paper
• An Overview of Short-Bowel Syndrome in Pediatric Patients: Focus on Clinical Management and Prevention of Complications

  2023cites this paper
• The assessment of the effectiveness and safety of teduglutide in the treatment of children with chronic intestinal insufficiency. A systematic review

  2023cites this paper
• Muscle hypertrophy and neuroplasticity in the small bowel in short bowel syndrome

  2023cites this paper
• The effect of hepatocyte growth factor on intestinal adaption in an experimental model of short bowel syndrome

  2023cites this paper
• Teduglutide in pediatric intestinal failure: A position statement of the Italian society of pediatric gastroenterology, hepatology and nutrition (SIGENP).

  2022cites this paper
• Expression, purification and molecular dynamics simulation of extracellular domain of glucagon-like peptide-2 receptor linked to teduglutide.

  2021cites this paper
• The Applications of the Recellularization Organs in Organ Replacement at the Stage of Animal Research

  2021cites this paper
• Proteomic biomarkers in short bowel syndrome : are we ready to use them in clinical activity?

  2021cites this paper
• Nutritional and pharmacological strategy in children with short bowel syndrome

  2021cites this paper
• Complications: Short Gut Syndrome

  2020cites this paper
• Constitutive Activation of Nrf2 in Mice Expands Enterogenesis in Small Intestine Through Negative Regulation of Math1

  2020cites this paper
• Repair and regeneration of small intestine: A review of current engineering approaches.

  2020cites this paper
• Designing novel teduglutide analogues with improved binding affinity: An in silico peptide engineering approach.

  2020cites this paper
• Parenteral Nutrition-Dependent Children With Short-Bowel Syndrome Lack Duodenal-Adaptive Hyperplasia but Show Molecular Signs of Altered Mucosal Function.

  2020cites this paper
• GLP-2 Analogues as First Specific Treatment of Intestinal Failure

  2019cites this paper
• Short Bowel Syndrome as the Leading Cause of Intestinal Failure in Early Life: Some Insights into the Management

  2019cites this paper
• Influence of Growth Factors on the Development of Necrotizing Enterocolitis.

  2019cites this paper
• The Effects of Gestational Psychological Stress on Neonatal Mouse Intestinal Development.

  2019cites this paper
• Clustering of Zika viruses originating from different geographical regions using computational sequence descriptors.

  2019cites this paper
• Translation of Evidence Into Practice With Teduglutide in the Management of Adults With Intestinal Failure due to Short-Bowel Syndrome: A Review of Recent Literature.

  2019cites this paper
• Short Bowel Syndrome

  2019cites this paper
• Ghrelin stimulates intestinal adaptation following massive small bowel resection in parenterally fed rats

  2018cites this paper
• The Intestinotrophic Effects of Glucagon-Like Peptide-2 in Relation to Intestinal Neoplasia.

  2018cites this paper
• Teduglutide for the treatment of short bowel syndrome – a safety evaluation

  2018cites this paper
• Host-Gut Microbiota Crosstalk in Intestinal Adaptation

  2018cites this paper
• Short bowel syndrome results in increased gene expression associated with proliferation, inflammation, bile acid synthesis and immune system activation: RNA sequencing a zebrafish SBS model

  2017cites this paper
• Predictors of a successful outcome for infants with short bowel syndrome: a 30-year single-institution experience

  2017cites this paper
• Intestinal Failure: Etiologies and Outcomes and Decision-Making Between Rehabilitation and Transplantation

  2017cites this paper
• The unrecognized occupational relevance of the interaction between engineered nanomaterials and the gastro-intestinal tract: a consensus paper from a multidisciplinary working group

  2017cites this paper
• Teduglutide: A Review in Short Bowel Syndrome

  2017cites this paper
• Short-term oral exposure to low doses of nano-sized TiO2 and potential modulatory effects on intestinal cells.

  2017cites this paper
• Prolonged Absence of Mechanoluminal Stimulation in Human Intestine Alters the Transcriptome and Intestinal Stem Cell Niche

  2017cites this paper
• Teduglutida: revisión de su uso en el síndrome de intestino corto

  2016cites this paper
• Clinical Outcomes of Pediatric Intestinal Failure Management after Implementation of a Multidisciplinary Intestinal Rehabilitation Program

  2016influential citation
• Effect of Sildenafil on Pancreatic Epidermal Growth Factor Expression and β-cell Function

  2016cites this paper
• Fgf10 overexpression enhances the formation of tissue‐engineered small intestine

  2016influential citation
• Short bowel syndrome: treatment options

  2016cites this paper
• The administration of ghrelin improved hepatocellular injury following parenteral feeding in a rat model of short bowel syndrome

  2016cites this paper
• The Pathogenesis of Resection-Associated Intestinal Adaptation

  2016cites this paper
• [Not Available].

  2016cites this paper
• Intestinal Epithelial-Specific mTORC1 Activation Enhances Intestinal Adaptation After Small Bowel Resection

  2016cites this paper
• Short-Bowel Syndrome in Children — An Update in Management Strategies

  2015cites this paper
• IGF1 stimulates crypt expansion via differential activation of 2 intestinal stem cell populations

  2015cites this paper
• CALL FOR PAPERS Innovative and Emerging Technologies in GI Physiology and Disease Adult zebrafish intestine resection: a novel model of short bowel syndrome, adaptation, and intestinal stem cell regeneration

  2015cites this paper
• Intestinal adaptation following resection.

  2014influential citation
• Intestinal proteomics in pig models of necrotising enterocolitis, short bowel syndrome and intrauterine growth restriction

  2014cites this paper
• Growth hormone in the clinical management of the short bowel syndrome in a pig model

  2014cites this paper
• Physiological Features of Intestinal Adaptation Structural Changes Associated With Intestinal Adaptation

  2014influential citation
• Neonatal short bowel syndrome as a model of intestinal failure: physiological background for enteral feeding.

  2013cites this paper
• Ghrelin and glucagon-like peptide-2 increase immediately following massive small bowel resection.

  2013cites this paper
• The effect of ghrelin on cell proliferation in small intestinal IEC-6 cells.

  2013cites this paper
• Teduglutide: A Review of its Use in the Treatment of Patients with Short Bowel Syndrome

  2013cites this paper
• Adaptation: paradigm for the gut and an academic career.

  2013cites this paper
• The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis.

  2013cites this paper
• Early enteral fat supplement and fish oil increases fat absorption in the premature infant with an enterostomy.

  2013cites this paper
• Short Bowel Syndrome in Children

  2012cites this paper
• Ret heterozygous mice have enhanced intestinal adaptation after massive small bowel resection.

  2012cites this paper
• Intestinal mucosal atrophy and adaptation.

  2012cites this paper
• Insulin-like growth factor 1: common mediator of multiple enterotrophic hormones and growth factors

  2012cites this paper
• Growth and growth hormone treatment in children with chronic diseases.

  2012cites this paper
• Ventromedial hypothalamic lesions enhance small intestinal cell proliferation in mice.

  2012cites this paper
• Current practice and future perspectives in the treatment of short bowel syndrome in children—a systematic review

  2012influential citation
• The therapeutic potential of targeting the glucagon-like peptide-2 receptor in gastrointestinal disease

  2011cites this paper
• Management of short bowel syndrome

  2011cites this paper